5F-PB22 is a fairly common designer research chemical that is commonly used as a cannabinoid agonist. A keen study of the 5F-PB22's intricate outlook reveals the underlying fact that the first inventors of the research compound had a thorough grasp of the structure-activity correlation obtaining within the indole grouping of cannabinoids. 

In the scientific world, a designer substance is a functional analog that's imitatively choreographed to work like another pre-existing formula. It means 5F-PB22 was manufactured based on some existing compositions with similar reactive outcomes. 

A cannabinoid agonist, on the other hand, is a specifically formulated compound that acts on the body to trigger bodily results comparable to those elicited by cannabinoid-containing substances although it affects different groups of receptors.

Seeing the precise category under which the chemical composition of 5F-PB22 falls, it becomes quite evident that the vitally essential research product was meant to aid the complex study of the human brain and the various behavioral patterns occasioned by different cannabinoid-rich stimulants such as the hemp plant leaves(cannabis sativa). 

In the pharmacological circles, 5F-PB22 is employed as a full agonist in various scientific operations and experiments. The research chemical has been found to have impressive binding affinity levels of 0.468nM at CB1 and 0.633nM at CB2 cannabinoid receptors. 

Given the fact that the formulation is among the least studied varieties in the extremely broad specialties described under Chemistry as a scholastic subject, many researchers have currently embarked on an in-depth analysis of 5F-PB22. The central pattern of this research compound shows that nitrogen at position one on the universal indole chain has been replaced with a fluoropentyl linkage that's akin to that of indazole cannabinoid variety 5F-PB22. 

Further on the nitrogen-based substitutions evidenced in this research chemical's structural outline, he third stage of the indole class chain, 5F-PB22 features another conspicuous "designer" inclusion of a methyl ester that's accordingly joined to a quinoline moiety situated at position eight relative nitrogen location in the synthetic research substance. 

Presently, this research chemical is undergoing intensive lab scrutiny in China and the United States. 

Due to the many pretty interesting phenomena exhibited by this cannabinoid agonist, the two nations mentioned above have been intensively occupied with its exploratory study for over a decade now. As such, the positively expectant global scientific and pharmaceutical community looks forward to receiving a few deeper insights about this novel research compound soon. 

Click to buy 5F-PB22 directly on our site.